Publication age and reagent-literature bias Much of the foundational, peer-reviewed pharmacology of Long R3 IGF-1 dates from the late 1980s and 1990s, when the analog was developed as a tool for dissecting IGFBP-versus-receptor contributions to potency and for biotechnology applications such as cell-culture media
eClinicalMedicine 57:101865
Based on the current Phase I results, CT-996 will advance into Phase II clinical development
One of our qualified healthcare professionals will be more than happy to provide personalised guidance and support, ensuring you feel confident and well-supported throughout your treatment journey
Components of the ECS are present in DCs, including CB1 and CB2 in addition to anandamide, 2-AG and FAAH [108]
Understanding Plateaus in Weight Loss Have you ever experienced the frustration of hitting a weight loss plateau